THREE ARCH ASSOCIATES IV LP
Insider CIK 1276986 · CNCE 10% owner · ACRX 10% owner · NVRO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 126,153 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 3,347,357 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 179,962 | — | $0 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2018-05-21 | 2018-05-23 | 5,713,569 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 244,600 | $12.29 | $3.01M | 557,126 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | S Sale | 2014-11-18 | 2014-11-20 | 5,400 | $12.29 | $66.4K | 12,301 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 682,475 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 1,272,187 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 204,076 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 28,090 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 15,069 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion deriv | 2014-11-12 | 2014-11-12 | 4,506 | — | $0 | 0 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 1,272,187 | — | $0 | 1,276,263 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 682,475 | — | $0 | 1,958,738 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 204,076 | — | $0 | 2,162,814 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 28,090 | — | $0 | 28,180 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 4,506 | — | $0 | 47,755 | SEC↗ |
| NVRO NEVRO CORP | C Conversion | 2014-11-12 | 2014-11-12 | 15,069 | — | $0 | 43,249 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,467,595 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 32,405 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 391,359 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 1,956,794 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 8,641 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion deriv | 2014-02-19 | 2014-02-21 | 43,206 | — | $0 | 0 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 346,335 | — | $0 | 631,195 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 5,735 | — | $0 | 6,289 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 101,264 | $14.00 | $1.42M | 801,726 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | P Buy | 2014-02-19 | 2014-02-21 | 2,236 | $14.00 | $31.3K | 17,701 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 69,267 | — | $0 | 700,462 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 259,751 | — | $0 | 284,860 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 1,529 | — | $0 | 15,465 | SEC↗ |
| CNCE CONCERT PHARMACEUTICALS, I | C Conversion | 2014-02-19 | 2014-02-21 | 7,647 | — | $0 | 13,936 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-12-07 | 2012-12-11 | 2,364,705 | $3.31 | $7.83M | 6,323,534 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-12-07 | 2012-12-11 | 52,213 | $3.31 | $172.8K | 139,621 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 4,151 | $0.13 | $540 | 4,151 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 60,789 | $0.13 | $7.9K | 60,789 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 3,268 | $0.13 | $425 | 3,268 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-06-06 | 188,020 | $0.13 | $24.4K | 188,020 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 208,911 | $3.40 | $710.3K | 3,958,829 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 67,543 | $3.40 | $229.6K | 3,704,712 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 3,631 | $3.40 | $12.3K | 199,174 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-06-06 | 4,613 | $3.40 | $15.7K | 87,408 | SEC↗ |